Avidity Partners Management LP Ultragenyx Pharmaceutical Inc. Transaction History

Avidity Partners Management LP

$1.63 Billion
Q3 2024

A detailed history of Avidity Partners Management LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 752,000 shares of RARE stock, worth $33.7 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares

752,000

Previous 960,000 21.67%

Holding current value

$33.7 Million

Previous $39.5 Million 5.87%

% of portfolio

2.56%

Previous 1.94%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $8.36 Million - $12.3 Million	-208,000 Reduced 21.67%	752,000 $41.8 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $991,630 - $1.37 Million	26,500 Added 2.84%	960,000 $39.5 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $3.83 Million - $4.78 Million	89,000 Added 10.54%	933,500 $43.6 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $9.53 Million - $14.8 Million	300,500 Added 55.24%	844,500 $40.4 Million
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $12.5 Million - $16.6 Million	-356,700 Reduced 39.6%	544,000 $19.4 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $45.8 Million - $63.9 Million	-1,226,200 Reduced 57.65%	900,700 $41.5 Million
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $31.9 Million - $42 Million	-863,100 Reduced 28.87%	2,126,900 $85.3 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $31.6 Million - $43.5 Million	938,400 Added 45.74%	2,990,000 $139 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $22.9 Million - $37.8 Million	572,100 Added 38.67%	2,051,600 $85 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $28 Million - $52.1 Million	610,500 Added 70.25%	1,479,500 $88.3 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $10.5 Million - $14.3 Million	169,000 Added 24.14%	869,000 $63.1 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $18.1 Million - $21.5 Million	245,000 Added 53.85%	700,000 $58.9 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $35.5 Million - $46.6 Million	455,000 New	455,000 $41 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Ultragenyx Pharmaceutical Inc. Transaction History